The development of a platform to rapidly identify tumor antigene-specific T cells receptors for therapy
People
(Responsible)
Additional information
Start date
01.04.2019
End date
31.10.2020
Duration
19 Months
Funding sources
Status
Ended
Category
Innosuisse /
Innovation projects